Search

Author/Creator McKone, Edward F

1. Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study. Issue 2 (February 2017)

Authors:
Konstan, Michael W; McKone, Edward F; Moss, Richard B; Marigowda, Gautham; Tian, Simon; Waltz, David; Huang, Xiaohong; Lubarsky, Barry; Rubin, Jaime; Millar, Stefanie J; Pasta, David J; Mayer-Hamblett, Nicole; Goss, Christopher H; Morgan, Wayne; Sawicki, Gregory S
Journal:
Lancet
Issue:
Volume 5:Issue 2(2017)
Page Start:
107
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis. Issue 2 (15th September 2017)

Authors:
Gray, Robert D; Hardisty, Gareth; Regan, Kate H; Smith, Maeve; Robb, Calum T; Duffin, Rodger; Mackellar, Annie; Felton, Jennifer M; Paemka, Lily; McCullagh, Brian N; Lucas, Christopher D; Dorward, David A; McKone, Edward F; Cooke, Gordon; Donnelly, Seamas C; Singh, Pradeep K; Stoltz, David A; Has...
Journal:
Thorax
Issue:
Volume 73:Issue 2(2018)
Page Start:
134
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial. Issue 3 (March 2022)

Authors:
Sutharsan, Sivagurunathan; McKone, Edward F; Downey, Damian G; Duckers, Jamie; MacGregor, Gordon; Tullis, Elizabeth; Van Braeckel, Eva; Wainwright, Claire E; Watson, Danie; Ahluwalia, Neil; Bruinsma, Bote G; Harris, Christopher; Lam, Anna P; Lou, Yiyue; Moskowitz, Samuel M; Tian, Simon; Yuan, Jas...
Journal:
Lancet
Issue:
Volume 10:Issue 3(2022)
Page Start:
267
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Issue 10212 (23rd November 2019)

Authors:
Heijerman, Harry G M; McKone, Edward F; Downey, Damian G; Van Braeckel, Eva; Rowe, Steven M; Tullis, Elizabeth; Mall, Marcus A; Welter, John J; Ramsey, Bonnie W; McKee, Charlotte M; Marigowda, Gautham; Moskowitz, Samuel M; Waltz, David; Sosnay, Patrick R; Simard, Christopher; Ahluwalia, Neil; Xua...
Journal:
Lancet
Issue:
Volume 394:Issue 10212(2019)
Page Start:
1940
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Issue 10212 (23rd November 2019)

Authors:
Heijerman, Harry G M; McKone, Edward F; Downey, Damian G; Van Braeckel, Eva; Rowe, Steven M; Tullis, Elizabeth; Mall, Marcus A; Welter, John J; Ramsey, Bonnie W; McKee, Charlotte M; Marigowda, Gautham; Moskowitz, Samuel M; Waltz, David; Sosnay, Patrick R; Simard, Christopher; Ahluwalia, Neil; Xua...
Journal:
Lancet
Issue:
Volume 394:Issue 10212(2019)
Page Start:
1940
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Increased extracellular vesicles mediate inflammatory signalling in cystic fibrosis. Issue 6 (7th April 2020)

Authors:
Useckaite, Zivile; Ward, Mark P; Trappe, Anne; Reilly, Rebecca; Lennon, Jenny; Davage, Holly; Matallanas, David; Cassidy, Hilary; Dillon, Eugene T; Brennan, Kiva; Doyle, Sarah L; Carter, Suzanne; Donnelly, Seamas; Linnane, Barry; McKone, Edward F; McNally, Paul; Coppinger, Judith A
Journal:
Thorax
Issue:
Volume 75:Issue 6(2020)
Page Start:
449
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. The future of cystic fibrosis care: a global perspective. Issue 1 (January 2020)

Authors:
Bell, Scott C; Mall, Marcus A; Gutierrez, Hector; Macek, Milan; Madge, Susan; Davies, Jane C; Burgel, Pierre-Régis; Tullis, Elizabeth; Castaños, Claudio; Castellani, Carlo; Byrnes, Catherine A; Cathcart, Fiona; Chotirmall, Sanjay H; Cosgriff, Rebecca; Eichler, Irmgard; Fajac, Isabelle; Goss, Chri...
Journal:
Lancet
Issue:
Volume 8:Issue 1(2020)
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysis. Issue 8 (8th June 2011)

Authors:
Jackson, Abaigeal D; Daly, Leslie; Jackson, Andrew L; Kelleher, Cecily; Marshall, Bruce C; Quinton, Hebe B; Fletcher, Godfrey; Harrington, Mary; Zhou, Shijun; McKone, Edward F; Gallagher, Charles; Foley, Linda; Fitzpatrick, Patricia
Journal:
Thorax
Issue:
Volume 66:Issue 8(2011)
Page Start:
674
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗